GGrantIndex
← Leaderboards

Duxin Sun

University Of Michigan At Ann Arbor

$5,692,004
Attributed
$6,734,291
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200725
$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,734,291 · 6

By mechanism

R01$5,030,225 · 3
P30$1,351,361 · 2
R21$352,705 · 1

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsMalignant NeoplasmsPharmaceutical PreparationsResearch PersonnelAnticancer ActivityResponseFuturePre-ClinicalImageBaseLymph NodesLeadCancer TherapyCancer Center Support GrantAntibodiesDrug DiscoveryDrug DevelopmentCostDrug KineticsLegal PatentAnti-Cancer TherapeuticGrantCancer CenterDosage

Grant awards (27)

Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy$529,077
R01 · FY2025 · CA · contact PI
Pharmacokinetics (PK)$209,831
P30 · FY2025 · CA · contact PI
Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy$529,077
R01 · FY2024 · CA · contact PI
Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity$513,210
R01 · FY2024 · AI · contact PI
Pharmacokinetics (PK)$201,830
P30 · FY2024 · CA · contact PI
Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity$513,210
R01 · FY2023 · AI · contact PI
Pharmacokinetics (PK)$206,230
P30 · FY2023 · CA · contact PI
Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity$513,210
R01 · FY2022 · AI · contact PI
Pharmacokinetics (PK)$138,838
P30 · FY2022 · CA · contact PI
Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity$513,210
R01 · FY2021 · AI · contact PI
Pharmacokinetics (PK)$141,425
P30 · FY2021 · CA · contact PI
Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity$513,210
R01 · FY2020 · AI · contact PI
Pharmacokinetics (PK)$141,425
P30 · FY2020 · CA · contact PI
Pharmacokinetics (PK)$141,427
P30 · FY2019 · CA · contact PI
Pharmacokinetics (PK)$141,349
P30 · FY2018 · CA · contact PI
Pharmacokinetics (PK)$9,970
P30 · FY2018 · CA · contact PI
Pharmacokinetics (PK)$8,972
P30 · FY2018 · CA · contact PI
Pharmacokinetics (PK)$7,663
P30 · FY2018 · CA · contact PI
Pharmacokinetics (PK)$2,401
P30 · FY2018 · CA · contact PI
An integrated system for tumor detection and targeted drug therapy of cancer$269,566
R01 · FY2011 · CA · contact PI
New molecular target and its inhibitors for use against pancreatic cancer$125,770
R21 · FY2011 · CA · contact PI
An integrated system for tumor detection and targeted drug therapy of cancer$278,809
R01 · FY2010 · CA · contact PI
New molecular target and its inhibitors for use against pancreatic cancer$226,935
R21 · FY2010 · CA · contact PI
An integrated system for tumor detection and targeted drug therapy of cancer$281,067
R01 · FY2009 · CA · contact PI
An integrated system for tumor detection and targeted drug therapy of cancer$225,862
R01 · FY2008 · CA · contact PI
An integrated system for tumor detection and targeted drug therapy of cancer$65,717
R01 · FY2008 · CA · contact PI
An integrated system for tumor detection and targeted drug therapy of cancer$285,000
R01 · FY2007 · CA · contact PI